Recent advances in pharmacologic neuroprotection

European Journal of Anaesthesiology

Volumn 27, Issue 1, 2010, Pages 6-10

  Mantz, Jean ^a,b   Degos, Vincent ^b   Laigle, Christophe ^c  

^a BEAUJON HOSPITAL   (France)

^b INSERM   (France)

^c AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Anaesthetics; Erythropoietin; Hypothermia; Neuroprotection; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; DEXMEDETOMIDINE; DIPYRIDAMOLE; DISUFENTON SODIUM; ERYTHROPOIETIN; LIDOCAINE; MEVINOLIN; NEUROPROTECTIVE AGENT; NPO 31112; RILUZOLE; UNCLASSIFIED DRUG; XENON;

APOPTOSIS; BRAIN INJURY; BRAIN ISCHEMIA; CELL MEMBRANE DEPOLARIZATION; CLINICAL TRIAL; EXCITOTOXICITY; FIBRINOLYTIC THERAPY; GRAY MATTER; HUMAN; HYPEROXIA; HYPOTHERMIA; INFLAMMATION; NERVE CELL NECROSIS; NERVE REGENERATION; NEUROPROTECTION; NONHUMAN; OPTIMAL DRUG DOSE; OXIDATIVE STRESS; PERIOPERATIVE PERIOD; REPERFUSION; REVIEW; SODIUM CALCIUM EXCHANGE; WHITE MATTER; ANESTHESIA; ANIMAL; DRUG EFFECT; METHODOLOGY; NERVE CELL; PATHOLOGY; REPERFUSION INJURY; STROKE; TREATMENT OUTCOME;

ANESTHESIA; ANIMALS; APOPTOSIS; BRAIN ISCHEMIA; CLINICAL TRIALS AS TOPIC; HUMANS; HYPOTHERMIA; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; REPERFUSION INJURY; RESEARCH DESIGN; STROKE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 77449145621     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32832fa606     Document Type: Review

References (26)

1. Fisher M, Brott TG. Emerging therapies for acute ischemic stroke: new therapies on trial. Stroke 2003; 34:350-361.
2. Degos V, Loron G, Mantz J, Gressens P. Neuroprotectives strategies for the neonatal brain. Anesth Analg 2008; 106:1670-1680.
3. Singhal AB, Lo EH, Dalkara T, Moskowitz MA. Advances in stroke neuroprotection: hyperoxia and beyond. Neuroimag Clin N Am 2005; 15:697-720.
4. Palace J. Neuroprotection and repair. J Neurol Sci 2008; 265:21-25.
5. Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 2007; 87:179-197.
6. Hossmann KA. Pathophysiology and therapy of experimental stroke. Cell Mol Neurobiol 2006; 26:1057-1083.
7. Green AR. Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly. Br J Pharmacol 2008; 153 (Suppl 1):S325-S338.
8. Kakuda W, Abo M. Intravenous administration of a tissue plasminogen activator beyond 3 h of the onset of acute ischemic stroke: MRI-based decision making. Brain Nerve 2008; 60:1173-1180.
9. Diener HC, Lees KR, Lyden P, et al. NXY-059 for the treatment of acute stroke: pooled analysis of the SAINT I and II trials. Stroke 2008; 39:1751-1758.
10. Elkind MS, Sacco RL, MacArthur RB, et al. The neuroprotection with statin therapy for acute recovery trial (NeuSTART): an adaptive design phase I dose-escalation study of high dose lovastatin in acute ischemic stroke. Int J Stroke 2008; 3:210-218.
11. Luna-Medina R, Cortes-Canteli M, Sanchez-Galiano S, et al. NPO31112, a thiadizolidinone compound, prevents inflammation and neurodegeneration under excitotoxic conditions: potential therapeutic role in brain disorders. J Neurosci 2007; 27:5766-5776.
12. Wang Q, Gou X, Xiong L, et al. Transactivator of transcription-mediated delivery of NEP1-40 protein into brain has a neuroprotective effect against focal cerebral ischemic injury via inhibition of neuronal apoptosis. Anesthesiology 2008; 108:1071-1080.
13. Zhang M, Martin BR, Adler MW, et al. Modulation of the balance between cannabinoid CB1 and CB2 receptor activation during cerebral ischemic/reperfusion injury. Neuroscience 2008; 152:753-760.
14. Fornai F, Longone P, Casafaro L, et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 2008; 105:2052-2057.
15. Verdonck O, Lahrech H, Francony G, et al. Erythropoietin protects from posttraumatic brain edema in the rat brain. J Cereb Blood Flow Metab 2007; 27:1-8.
16. Rabie T, Marti HH. Brain protection by erythropoietin: a manifold task. Physiology 2008; 23:263-274.
17. Leist M, Ghezzi P, Grasso M, et al. Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 2004; 305:239-242.
18. The Hypothermia after Cardiac Arrest Study group: Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002; 346:549-556.
19. Todd M, Hindman B, Clarke WR, Torner JC. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med 2005; 352:135-145.
20. Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007; 298:2644-2653.
21. Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA 2009; 301:489-499.
22. Kitano H, Kirsch JR, Hurn PD, Murphy SJ. Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain. J Cereb Blood Flow Metab 2007; 27:1108-1128.
23. Bayliss DA, Barrett PQ. Emerging role for two-pore-domain potassium channels and their potential therapeutic impact. Trends Pharmacol Sci 2008; 29:566-575.
24. Sigaut S, Jannier V, Rouelle D, et al. Preconditioning effect of sevoflurane on the oxygen glucose deprived hippocampal slice: role of tyrosine kinases and duration of ischemia. Anesth Analg 2009; 108:601-608.
25. Codaccioni JL, Velly L, Moubank C, et al. Sevoflurane preconditioning against focal ischemia. Inhibition of apoptosis in the face of transient improvement of neurological outcome. Anesthesiology 2009; 110:1271-1278.
26. Lee JJ, Li L, Jung HH, Zuo Z. Postconditioning with isoflurane reduced ischemia-induced brain injury in rats. Anesthesiology 2008; 108:1055-1062.